Followers | 49 |
Posts | 4149 |
Boards Moderated | 1 |
Alias Born | 05/20/2014 |
![](https://investorshub.advfn.com/uicon/479896.png?cb=1595676177)
Wednesday, October 25, 2023 4:25:54 AM
Our pipeline is positioned to deliver both near-term and sustained growth in two waves:? In the near-term, the OTC formulation launch through FY2023 will start bringing a steady revenue stream, representing best-in-class or first-in-class therapies. Looking to FY2024 and beyond, our R&D engine with internal research capabilities and external partnerships is expected to deliver a steady stream of next-generation pain therapies that will sustain our growth.
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM